COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX Russian patent published in 2011 - IPC A61K47/22 A61K47/32 A61K9/20 A61K31/00 A61J3/10 A61K8/00 

Abstract RU 2423997 C9

FIELD: medicine, pharmaceutics.

SUBSTANCE: composition for medical use contains a solid or semisolid matrix, at least one active ingredient uniformly dispersed therein. The matrix contains at least one pharmaceutically acceptable matrix-forming agent and compound 1,3-bis(lactamyl)butane, especially 1,3-bis(pyrrolidone-1-yl)butane. The active component has water-solubility less than 1 g/100 ml at 25°C. The active ingredient is preferentially dispersed in a matrix as a solid solution. The matrix-forming agent is chosen from a group of alcohol sugars, alcohol sugar derivatives, pharmaceutically acceptable polymers and their mixtures. The composition is used for preparing the pharmaceutical dosage forms for oral administration of the active ingredients.

EFFECT: composition provides higher bioavailability of poorly water-soluble active ingredient due to its presence in the composition in a non-crystalline state.

19 cl, 13 ex

Similar patents RU2423997C9

Title Year Author Number
PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION 2007
  • Lipol'D Bernd
  • Rozenberg Jorg
  • Knoblokh Martin
  • Nehen Kristian
RU2468788C2
PHARMACEUTICAL DOSED FORM, CONTAINING POLYMER CARRIER COMPOSITION 2009
  • Lipol'D Bernd
  • Brajtenbakh Jorg
  • Megerljajn Markus
  • Pakkhojzer Klaudija
  • Kessler Tomas
RU2519679C9
PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT 2007
  • Rozenberg Jorg
  • Brajtenbakh Jorg
  • Marsh Kennan
  • Lipol'D Bernd
  • Shmidt Kristof
  • Lander Ute
RU2469708C2
IMPROVED WAY OF PREPARATION OF THE ACTIVE COMPONENT FIRM DISPERSION 2007
  • Kessler Tomas
  • Brajtenbakh Jorg
  • Shmidt Kristof
  • Degenkhardt Mattias
  • Rozenberg Jorg
  • Krull' Kharal'D
  • Berndl Gunter
RU2442568C2
DEVICE FOR PREPARING SOLID DISPERSION OF ACTIVE INGREDIENT 2007
  • Kessler Tomas
  • Brajtenbakh Jorg
  • Shmidt Kristof
  • Degenkhardt Mattias
  • Rozenberg Jorg
  • Krull' Kharal'D
RU2448688C2
COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE 2003
  • Rozenberg Jorg
  • Degenkhardt Matias
  • Brajtenbakh Jorg
  • Rejlehnd Tom L.
  • Marsh Kennehn K.
RU2356549C2
PERORAL SOLID DOSAGE FORM WITH MYCOPHENOLIC ACID OR ITS SALT FOR USE AS AN IMMUNODEPRESSANT FOR TREATMENT OR PREVENTION OF ORGAN OR TISSUE TRANSPLANT REJECTION AND METHOD FOR PRODUCTION THEREOF 2016
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2670447C2
COMPOSITION CONTAINING FENOFIBRIC ACID OR PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND CAPSULE CONTAINING COMPOSITION 2008
  • Rozenberg Jorg
  • Degenkhardt Matias
  • Brajtenbakh Jorg
  • Rejlehnd Tom L.
  • Marsh Kennehn K.
RU2500398C2
HEPARIN-BASE FORMULATION 2001
  • Rozenberg Jorg
  • Brajtenbakh Jorg
  • Kherr Diter
  • Lauks Fol'Ker
  • Kheger Robert
RU2278658C2
EXTRUDATE WITH SODIUM MYCOPHENOLATE TO PRODUCE PERORAL SOLID DOSAGE FORM 2018
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2723255C2

RU 2 423 997 C9

Authors

Rozenberg Jorg

Mehgerljajn Markus

Brajtenbakh Jorg

Dates

2011-07-20Published

2006-06-22Filed